Ae Nim Pae,Hyunah Choo,Yong Seo Cho,Ahmed Asif,Woo-Kyu Park
申请号：
US12575235
公开号：
US08232279B2
申请日:
2009.10.07
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention relates to a novel medicinal use of pyrazolopyrimidine compounds having superior effect as serotonin 5-HT2C receptor ligand thus being useful for the prevention and treatment of central nervous system (CNS) diseases. Accordingly, the pharmaceutical composition comprising pyrazolopyrimidine compounds and their pharmaceutically acceptable salts as active ingredients are useful for the prevention and treatment of serotonin 5-HT2C-related central nervous system diseases such as obesity, depression, anxiety and withdrawal symptoms due to drug abuse.
